We are live on ! Find out more
GWM

Geneos Wealth Management Portfolio holdings

AUM $4.9B
1-Year Est. Return 23.65%
This Fund
S&P 500
This Quarter Est. Return
+6.9%
1 Year Est. Return
+23.65%
3 Year Est. Return
+66.72%
5 Year Est. Return
+71.27%
10 Year Est. Return
+298.51%
AUM
$3.94B
AUM Growth
-$152M
Cap. Flow
-$380M
Cap. Flow %
-9.65%
Top 10 Hldgs %
15.97%
Holding
3,250
New
141
Increased
508
Reduced
1,176
Closed
788
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FATE icon
2301
Fate Therapeutics
FATE
$326M
$2.27K ﹤0.01%
1,800
SBSW icon
2302
Sibanye-Stillwater
SBSW
$7.53B
$2.25K ﹤0.01%
+200
New +$1.75K
XRX icon
2303
Xerox
XRX
$425M
$2.2K ﹤0.01%
586
-70
-11% -$309
PGF icon
2304
Invesco Financial Preferred ETF
PGF
$672M
$2.19K ﹤0.01%
150
HST icon
2305
Host Hotels & Resorts
HST
$16B
$2.18K ﹤0.01%
128
-1,149
-90% -$19.1K
USRT icon
2306
iShares Core US REIT ETF
USRT
$4.64B
$2.17K ﹤0.01%
37
PCG icon
2307
PG&E
PCG
$38.5B
$2.17K ﹤0.01%
144
-905
-86% -$13.2K
SH icon
2308
ProShares Short S&P500
SH
$843M
$2.14K ﹤0.01%
58
VSS icon
2309
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.9B
$2.14K ﹤0.01%
15
LITE icon
2310
Lumentum
LITE
$69.3B
$2.12K ﹤0.01%
13
-232
-95% -$28.9K
SAM icon
2311
Boston Beer
SAM
$1.92B
$2.11K ﹤0.01%
10
KN icon
2312
Knowles
KN
$3.34B
$2.1K ﹤0.01%
90
-60
-40% -$1.23K
UTHR icon
2313
United Therapeutics
UTHR
$23.1B
$2.1K ﹤0.01%
5
-140
-97% -$47.1K
IBRX icon
2314
ImmunityBio
IBRX
$8.1B
$2.08K ﹤0.01%
847
SDG icon
2315
iShares MSCI Global Sustainable Development Goals ETF
SDG
$175M
$2.08K ﹤0.01%
25
GERN icon
2316
Geron
GERN
$949M
$2.06K ﹤0.01%
1,500
ADEA icon
2317
Adeia
ADEA
$3.11B
$2.05K ﹤0.01%
122
ALK icon
2318
Alaska Air
ALK
$5.58B
$2.03K ﹤0.01%
41
-198
-83% -$11K
ARI
2319
Apollo Commercial Real Estate
ARI
$885M
$2.03K ﹤0.01%
200
-82
-29% -$836
FFBC icon
2320
First Financial Bancorp
FFBC
$3.53B
$2.02K ﹤0.01%
80
-44
-35% -$1.11K
STE icon
2321
Steris
STE
$23.1B
$1.98K ﹤0.01%
8
-166
-95% -$39.7K
BHE icon
2322
Benchmark Electronics
BHE
$2.96B
$1.97K ﹤0.01%
51
AXSM icon
2323
Axsome Therapeutics
AXSM
$10.9B
$1.94K ﹤0.01%
16
-34
-68% -$3.83K
MAC icon
2324
Macerich
MAC
$6.92B
$1.91K ﹤0.01%
105
-33
-24% -$571
HITI
2325
High Tide
HITI
$202M
$1.88K ﹤0.01%
517

Similar funds

Geneos Wealth Management's Q3 2025 Portfolio in Review

As of Q3 2025, Geneos Wealth Management held 3,250 positions worth $3.94B, down 3.7% from $4.09B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Geneos Wealth Management withdrew a net $380M in Q3 2025, closing 788 positions and reducing 1,176 holdings. Its most notable exit was Hess, an estimated $4.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.6% a quarter earlier, followed by Financials and Industrials.

Against the trend, Geneos Wealth Management opened a new position in First Trust Exchange-Traded Fund IV First Trust High Income Strategic Focus ETF worth $12.6M.

  • Geneos Wealth Management's largest Q3 2025 buy was First Trust Exchange-Traded Fund IV First Trust High Income Strategic Focus ETF: 279,920 shares worth $12.6M.
  • Geneos Wealth Management added most to Capital Group Growth ETF in Q3 2025, an estimated $17.6M increase.
  • Geneos Wealth Management's biggest Q3 2025 reduction was Schwab US Large-Cap Growth ETF, cutting an estimated $20.7M.
  • Geneos Wealth Management fully exited Hess in Q3 2025, selling an estimated $4.6M.
  • Geneos Wealth Management's ten largest holdings make up 16% of its $3.94B portfolio in Q3 2025.
  • Geneos Wealth Management opened 141 new positions and closed 788 in Q3 2025.
  • Geneos Wealth Management's portfolio value fell 3.7% quarter-over-quarter to $3.94B.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.